Top 5% Biotech, Insmed, Hits A Record High On Its 'Skeleton Key' Approval
Tuesday, 12 August 2025 ()
Insmed stock hit a record high Tuesday after the FDA approved its drug, brensocatib, for patients with a devastating lung condition.
|
||||
You Might Like |
||||
